RSS

NSF International

A health sciences and regulatory company is expanding its services to the European Union’s medical device, pharmaceutical and manufacturing industries. Read more

News

Here, Jim Morris from NSF International, summarises the benefits of an excipient GMP certification programme (ECP) both from the point of view of the excipient manufacturer and the excipient customer. Read more

Opinion

In this article, John Johnson, vice president, Pharma Biotech, NSF International, looks at the revision to Annex 1 and the important questions steriles manufacturers and pharma suppliers should be asking themselves. Read more

Opinion

In this article, NSF International goes into detail about what the potential ramifications of Brexit may be on the regulatory landscape in pharma. Read more

Opinion

Global health organisation NSF International has acquired the auditing subsidiary of the International Pharmaceutical Excipients Council of the Americas (IPEC-Americas): IPEA. These audits are important as US and European regulations, and pending... Read more

Technology

The International Pharmaceutical Excipients Council of the Americas (IPEC-Americas), a non-profit trade association, has agreed to sell IPEA, its wholly owned Excipient Auditing and Certification subsidiary, to NSF International. Read more

Technology

NSF International now has Atorvastatin Calcium Reference Standard Kits, which are traceable to official US and European pharmacopeial (USP and EP) standards. Read more

Technology

In this article, NSF International goes into detail about what the potential ramifications of Brexit may be on the regulatory landscape in pharma. Read more

Opinion